Page 118 - 2021 IDMT Digital

BASAL CELL CARCINOMA
Introduction:
• 0RVW FRPPRQ IRUP RI VNLQ FDQFHU; metastasis is rare (<1%)
o /HVLRQV RI IDLU VNLQQHG LQGLYLGXDOV RQ VXQ H[SRVHG VNLQ
o 3DSXOHV RQ VXQ H[SRVHG VNLQ LQ RWKHUZLVH QRUPDO IDLU VNLQQHG LQGLYLGXDOV
• 8VXDOO\ VLJQLILFDQW KLVWRU\ RI VXQ H[SRVXUH RIWHQ LQWHQVH LQWHUPLWWHQW

Subjective:
• 6LJQV DQG 6\PSWRPV
o 0RVW FRPPRQ SUHVHQWDWLRQ SDSXOH RU QRGXOH WKDW PD\ KDYH D FHQWUDO VFDE RU
HURVLRQ
o /HVLRQV JURZ VORZO\ RYHU \HDUV DWWDLQLQJ D VL]H RI FP RU PRUH LQ GLDPHWHU
o 0D\ KDYH D KLVWRU\ RI EOHHGLQJ
• )RFXVHG +LVWRU\
o 3HUVRQDO KLVWRU\ RI LQWHQVH SHHOLQJ VXQEXUQV
o 6XQVFUHHQ XVDJH
o &KDQJHV WR WKH OHVLRQ V $%&'( UXOH
Objective:
• 3K\VLFDO ([DP
o )XOO VNLQ H[DP
o $SSHDUDQFH ZD[\ SHDUO\ RU WUDQVOXFHQW SDSXOHV HU\WKHPDWRXV SDWFK ! PP
RU QRQ KHDOLQJ XOFHU LQ VXQ H[SRVHG DUHDV IDFH WUXQN ORZHU OHJV
Assessment:
• 'LIIHUHQWLDO
o 0HODQRF\WLF QHYL QRUPDO PROHV VPDOO OHVLRQV ZLWK D ZHOO GHILQHG ERUGHU DQG
VLQJOH VKDGH RI SLJPHQW
o 6HERUUKHLF NHUDWRVLV EHQLJQ SODTXHV ZLWK D YHOYHW\ RU ZDUW\ VXUIDFH DSSHDU WR
EH VWXFN RQWR WKH VNLQ
o $FWLQLF NHUDWRVLV PDFXOHV DQG SDSXOHV RQ VXQ H[SRVHG DUHDV IHHOV OLNH
VDQGSDSHU
o 6TXDPRXV FHOO FDUFLQRPD QRQ KHDOLQJ XOFHU RU ZDUW\ QRGXOH
o 0DOLJQDQW PHODQRPD $%&'( LUUHJXODULWLHV
Plan:
• 7UHDWPHQW UHIHUUDO IRU H[FLVLRQ
Patient Education:
• $OZD\V XVH VXQVFUHHQ DQG VXQ SURWHFWLYH PHDVXUHV
• )ROORZ XS $FWLRQV
o 5HIHUUDO IRU H[FLVLRQ DQG HQFRXUDJH FRPSOLDQFH ZLWK VSHFLDOW\ UHFRPPHQGDWLRQV
o 5HWXUQ IRU IXUWKHU HYDOXDWLRQ IRU DQ\ QHZ VXVSLFLRXV OHVLRQV
Preceptor Directive:
• Blue Directive: Contact Preceptor Immediately

[ 117 ]